Farmavita.Net members, from India,  are offering  license-out  of formulation documentation for more than two hundred (200)  pharmaceutical products. Each CTDossier is available for lump sum payment, without supply obligation. This Dossiers does not include  clincal studies. 

 Click Here to download the complete list of available formulations, with example of Dossier Table of Contents, for one product. 

It is expected that buyer of documentation will find own API supplier, make validation batches, complete the Dossier and continue with own manufacture and sales. 

Complete contract R&D service is available for any other pharmaceutical product which is not listed.

  Click Here to download the complete list of available formulations, with example of Dossier Table of Contents, for one product.  

If you are interested in any of this products please contact us. Within your inquery you shoud put detials about in-license teritory and forecast of sales for minimum 3 years. 

Any offer for sales of intellectual property is valid subject to confirmation, country by country. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights. Farmavita.Net is not owner of offered products/licenses and do not take any liability related to them. However, as the licensing agent Farmavita.Net will do the best to facilitate that closed licensing agreements are made on mutual benefit of contracting parties and without infringement of intellectual property of third parties. 

Comments

Search RSS

monagogia  - Ms   |Author |2007-04-12 05:43:12 For all the 200 dossiers and wherever applicable, is the bio-equivalence assured against the EU reference product?

zmauko  - Bio-equivalence   |Administrator |2007-04-12 15:26:10 This depends about specific product. For injectable products and applications under "Article 10a - well established use" there is no need for BE studies. Please, send me the private message with your specific needs. Kind regards, Zdravko Mauko CEO Farmavita.Net

tushars  - i am intrested   |Registered |2007-05-30 10:39:26 Hi! I want the dossiers for Nigeria and Uganda markets. Let me know the cost for the following:. Esomeprazole : 20mg ; 40mg : Tablets Esomeprasole + Domeperidone:40mg + 30mg Omeprazole : 10mg ; 20mg Capsules Omeprazole : 40mg inj. Pantoprazole : 40mg Inj Regards, TS

pedja   |Registered |2007-09-27 12:46:32 Requesting Domepridone 10mg Tablets dossier for Serbia. Please contact.

bunmap_houston   |Author |2007-07-17 11:48:52 I'm interested in Ambroxol hcl 30mg tablet and Oxethazaine + Aluminium Hydroxide + Magnesium Hydroxide : 10mg/5ml + 291mg/5ml + 98mg/5ml : Gel Let me know the information

fatihtekkol  - about omeprazol 20mg+domperido   |Author |2007-08-11 11:59:07 I am interested in omeprazole20mg domperidon 10 mg capsules. Is the CTD of this porduct acceped by EU? DOse it have clinical tirals or is it being sold in US or EU pharmaceutical market? Will the CTD dossier contain this infromations. Best regards Ph Fatih TEKKOL

Rizvan Kassam  - dossiers   |Author |2008-02-15 10:38:59 please let me have more details of the dossiers

Daniela Zelaschi  - Need fo help in using Farmavit   |Author |2008-02-15 10:39:23 Hello, I am interested in getting directly in touch with the Company offering the dossiers. How to do it?? Thanks DZ

Zdravko Mauko  - Getting directly in touch with     |Administrator |2008-02-25 08:59:54 Dear Sir, To get in direct touch with members/companies offering or demanding dossiers you should give us the following introductory information: 1. Short information about your company, annual turnover. 2. Information about desired license territory. 3. What kinf of license do you need? Exclusive or non-exclusive? With supply or without supply? 3. Forecast of sales for at least 3 years. It is the best if your can give IMS sales data for license territory , with indication of your target market share. We need this data to prepare the quotation and put you in contact with owner of Dossier. You can send your data to info(at)farmavita.net or ceo(at)farmavita.net. Kind regards, Zdravko Mauko CEO Farmavita.Net

Daniela Zelaschi  - Tolterodine Tartrate   |Author |2008-02-15 10:39:32 Hello, I could be interested in Tolderodine Tartrate for some EU territories. Is the dossier completed with Bioequivalence study? Is the 4 mg. dose the Retard? What is the cost? Please contact DZ

Zdravko Mauko  - Getting directly in touch with     |Administrator |2008-02-25 09:00:03 Dear Sir, There is no offer for Tolderodine Tartrate in the database. Maybe some member will see your demand and get in touch with you. It is better to publish your demand in "In-license Section" using the button "Submit License Need" at your member menu, at the right side bar. Regard, Zdravko

Qamar Nawaz   |Author |2009-03-10 23:28:13 I am interested in the dossiers for following: Amoxicillin caps 250mg and 500mg for the UK market. Would be grateful if you can let me know of the prices. projected sales: first year £10,000. Second year £20,000. Third year £50,000. these figures are cautious projections as the UK market is already saturated. I am also interested in procuring CTD dossier for Omeprazole 10mg capsules. Oxybutinin syrup 2.5mg/5ml Thanking you in anticipation. Dr Qamar Sterling Pharmaceuticals Ltd 288 Upper balsall heath rd Moseley Birmingham UK We are a small pharmaceutical manufacturing company and are licensed by MHRA for the production of licensed products.

Only registered users can write comments!

Powered by !JoomlaComment 3.26

3.26 Copyright (C) 2008 Compojoom.com / Copyright (C) 2007 Alain Georgette / Copyright (C) 2006 Frantisek Hliva. All rights reserved."

• PharmaBrand (03/03/2010)
• Pain Market Overview (19/02/2010)
• Anti Counterfeit Packaging Technologies (11/02/2010)

• Bisoprilol (06/09/2006)
• Lacidipin (06/09/2006)
• Meloxicam (06/09/2006)
• Ramipril (06/09/2006)
• Triamterene/HCTZ (19/08/2006)
• Triamterene/Epitiazide (19/08/2006)
• Triamterene (19/08/2006)
• Torfenamide (19/08/2006)
• Tolbutamide (19/08/2006)